Download video

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

799 views

U.S. Food and Drug Administration

10 years ago

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

Inborn Errors of Metabolism, Parents, and the FDA
4:58
Inborn Errors of Metabolism, Parents, and the FDA
by Rare Disease Report
Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1
2:08:17
Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1
by U.S. Food and Drug Administration
Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1
1:39:37
Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1
by U.S. Food and Drug Administration
Public Meeting on Patient Focused Drug Development for Psoriasis Part 1
2:26:08
Public Meeting on Patient Focused Drug Development for Psoriasis Part 1
by U.S. Food and Drug Administration
USMLE Review - Pediatrics (Inborn Errors of Metabolism)
1:50:47
USMLE Review - Pediatrics (Inborn Errors of Metabolism)
by Matthew McGlothlin
Inborn Errors of Metabolism: What Clinicians Need to Know About Metabolic Disorders
1:19:55
Inborn Errors of Metabolism: What Clinicians Need to Know About Metabolic Disorders
by MedGenome
Approach to metabolic disorders Part 2
25:17
Approach to metabolic disorders Part 2
by The Achiever's Edge By Dr Sandeep Sharma
Galactosemia Patient-Focused Drug Development (PFDD) Meeting
1:19
Galactosemia Patient-Focused Drug Development (PFDD) Meeting
by CheckRare
Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1
1:56:32
Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1
by U.S. Food and Drug Administration
Public Meeting on Patient Focused Drug Development for Alpha 1 Antitrypsin Part 2
3:06:28
Public Meeting on Patient Focused Drug Development for Alpha 1 Antitrypsin Part 2
by U.S. Food and Drug Administration
Niemann-Pick Type C Externally-led Patient-Focused Drug Development Meeting (Full Program)
6:13:00
Niemann-Pick Type C Externally-led Patient-Focused Drug Development Meeting (Full Program)
by Ara Parseghian Medical Research Fund
Impact of daily living in CLN2 Batten Disease -- FDA PFDD IEM Meeting June 2014
11:19
Impact of daily living in CLN2 Batten Disease -- FDA PFDD IEM Meeting June 2014
by Tracy VanHoutan
Inborn Errors of Metabolism made SUPER LOGICAL!!!! PART I
24:02
Inborn Errors of Metabolism made SUPER LOGICAL!!!! PART I
by Tala Talks NICU
Nonprofit Forum 2013: FDA: Patient Focused Drug Program
1:01:19
Nonprofit Forum 2013: FDA: Patient Focused Drug Program
by NIHNINDS
Pediatrics: Inborn Errors of Metabolism Part 3: Cases | Aseel Badukhon
35:55
Pediatrics: Inborn Errors of Metabolism Part 3: Cases | Aseel Badukhon
by PAL KSUMSC
2020 Symposium: FDA Oncology Center of Excellence Initiatives to Advance Patient Engagement
50:20
2020 Symposium: FDA Oncology Center of Excellence Initiatives to Advance Patient Engagement
by nhcouncil
Gene Therapy and Inborn Errors of Metabolism of the Liver
3:26
Gene Therapy and Inborn Errors of Metabolism of the Liver
by Rare Disease Report
PC EL-PFDD Meeting with FDA
3:39:46
PC EL-PFDD Meeting with FDA
by Pachyonychia Congenita Project
Treatable inborn errors of metabolism causing intellectual disability
1:08:39
Treatable inborn errors of metabolism causing intellectual disability
by UW Medicine Neurosciences Institute
Patient Focused Drug Development For Peroxisomal Disorders: What is it? How can I be a part of it?
38:00
Patient Focused Drug Development For Peroxisomal Disorders: What is it? How can I be a part of it?
by Global Foundation for Peroxisomal Disorders
September 21st, 2021: Monthly RDLA Webinar in Honor of Newborn Screening Awareness Month
1:10:45
September 21st, 2021: Monthly RDLA Webinar in Honor of Newborn Screening Awareness Month
by EveryLife Foundation for Rare Diseases